{"name": "Metabolic Solutions Development",
 "permalink": "metabolic-solutions-development",
 "crunchbase_url": "http://www.crunchbase.com/company/metabolic-solutions-development",
 "homepage_url": "http://www.msdrx.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "269.343.6732",
 "description": "",
 "created_at": "Sat Oct 23 10:13:27 UTC 2010",
 "updated_at": "Sat Oct 23 10:13:26 UTC 2010",
 "overview": "\u003Cp\u003EMetabolic Solutions Development Company (www.msdrx.com), based in Kalamazoo, Mich., is developing innovative therapeutics based upon a novel pharmacological path to treat type 2 diabetes. This innovative approach seeks to improve the efficacy of treatment by freeing patients from the adverse side effects of current treatments, including edema and weight gain. The company\u00e2\u20ac\u2122s scientific strategy is built on a historical understanding of insulin-sensitizers and its unique insight into the mechanism of insulin-sensitizing pharmacology. The company believes that its efforts will result in the creation of a new generation of superior, safer drug therapies to treat type 2 diabetes and other serious metabolic disorders.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       56],
      "assets/images/resized/0010/6896/106896v1-max-150x150.png"],
     [[188,
       71],
      "assets/images/resized/0010/6896/106896v1-max-250x250.png"],
     [[188,
       71],
      "assets/images/resized/0010/6896/106896v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Stephen",
      "last_name": "C. Benoit",
      "permalink": "stephen-c-benoit",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$23.5M",
 "funding_rounds":
  [{"round_code": "d",
    "source_url": "http://www.msdrx.com/resources/2010-1021-Phase-IIb-nr-FINAL.pdf",
    "source_description": "METABOLIC SOLUTIONS DEVELOPMENT COMPANY RAISES $23.5 MILLION",
    "raised_amount": 23500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 10,
    "funded_day": 24,
    "investments":
     [{"company":
        {"name": "Hopen Life Sciences",
         "permalink": "hopen-life-sciences",
         "image": null},
       "financial_org": null,
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "161 East Michigan Ave",
    "address2": "4th Floor",
    "zip_code": "49007",
    "city": "Kalamazoo",
    "state_code": "MI",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}